Citadel Advisors’s Veradigm Inc. Common Stock MDRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-92,900
| Closed | -$975K | – | 15772 |
|
|
2023
Q4 | $975K | Buy |
92,900
+75,100
| +422% | +$921K | ﹤0.01% | 6742 |
|
|
2023
Q3 | $234K | Buy |
17,800
+17,600
| +8,800% | +$231K | ﹤0.01% | 9623 |
|
|
2023
Q2 | $2.52K | Sell |
200
-2,500
| -93% | -$30.4K | ﹤0.01% | 13772 |
|
|
2023
Q1 | $35.2K | Buy |
2,700
+2,400
| +800% | +$38.9K | ﹤0.01% | 12576 |
|
|
2022
Q4 | $5.29K | Buy |
+300
| New | +$5.03K | ﹤0.01% | 14019 |
|
|
2021
Q4 | – | Sell |
-20,100
| Closed | -$269K | – | 15051 |
|
|
2021
Q3 | $269K | Sell |
20,100
-39,200
| -66% | -$633K | ﹤0.01% | 11311 |
|
|
2021
Q2 | $1.1M | Buy |
59,300
+45,400
| +327% | +$764K | ﹤0.01% | 8125 |
|
|
2021
Q1 | $209K | Sell |
13,900
-60,800
| -81% | -$974K | ﹤0.01% | 11609 |
|
|
2020
Q4 | $1.08M | Buy |
74,700
+63,300
| +555% | +$766K | ﹤0.01% | 6654 |
|
|
2020
Q3 | $93K | Sell |
11,400
-5,400
| -32% | -$44.1K | ﹤0.01% | 9308 |
|
|
2020
Q2 | $114K | Buy |
+16,800
| New | +$109K | ﹤0.01% | 8923 |
|
|
2019
Q4 | – | Sell |
-17,600
| Closed | -$193K | – | 9924 |
|
|
2019
Q3 | $193K | Buy |
+17,600
| New | +$181K | ﹤0.01% | 8178 |
|
|
2019
Q2 | – | Sell |
-37,600
| Closed | -$359K | – | 10025 |
|
|
2019
Q1 | $359K | Buy |
37,600
+25,700
| +216% | +$284K | ﹤0.01% | 7343 |
|
|
2018
Q4 | $115K | Sell |
11,900
-8,500
| -42% | -$94.8K | ﹤0.01% | 8188 |
|
|
2018
Q3 | $291K | Buy |
+20,400
| New | +$277K | ﹤0.01% | 7617 |
|
|
2018
Q1 | – | Sell |
-20,400
| Closed | -$297K | – | 8924 |
|
|
2017
Q4 | $297K | Buy |
+20,400
| New | +$283K | ﹤0.01% | 6484 |
|
|
2017
Q3 | – | Sell |
-57,300
| Closed | -$731K | – | 8187 |
|
|
2017
Q2 | $731K | Buy |
57,300
+40,600
| +243% | +$493K | ﹤0.01% | 4571 |
|
|
2017
Q1 | $212K | Buy |
+16,700
| New | +$198K | ﹤0.01% | 6418 |
|
|
2016
Q4 | – | Sell |
-28,200
| Closed | -$371K | – | 7996 |
|
|
2016
Q3 | $371K | Buy |
28,200
+17,600
| +166% | +$235K | ﹤0.01% | 5331 |
|
|
2016
Q2 | $135K | Sell |
10,600
-5,600
| -35% | -$74.3K | ﹤0.01% | 6061 |
|
|
2016
Q1 | $214K | Sell |
16,200
-17,300
| -52% | -$227K | ﹤0.01% | 5559 |
|
|
2015
Q4 | $515K | Sell |
33,500
-4,800
| -13% | -$68.8K | ﹤0.01% | 4432 |
|
|
2015
Q3 | $475K | Buy |
38,300
+15,000
| +64% | +$206K | ﹤0.01% | 4876 |
|
|
2015
Q2 | $319K | Buy |
23,300
+9,600
| +70% | +$130K | ﹤0.01% | 5662 |
|
|
2015
Q1 | $164K | Sell |
13,700
-3,000
| -18% | -$36.7K | ﹤0.01% | 6393 |
|
|
2014
Q4 | $213K | Buy |
16,700
+3,300
| +25% | +$42K | ﹤0.01% | 5911 |
|
|
2014
Q3 | $180K | Buy |
13,400
+3,100
| +30% | +$47K | ﹤0.01% | 5830 |
|
|
2014
Q2 | $165K | Buy |
10,300
+3,000
| +41% | +$46.8K | ﹤0.01% | 5772 |
|
|
2014
Q1 | $132K | Sell |
7,300
-6,500
| -47% | -$112K | ﹤0.01% | 5919 |
|
|
2013
Q4 | $213K | Sell |
13,800
-8,800
| -39% | -$130K | ﹤0.01% | 4967 |
|
|
2013
Q3 | $336K | Buy |
22,600
+4,600
| +26% | +$69.4K | ﹤0.01% | 4230 |
|
|
2013
Q2 | $233K | Buy |
+18,000
| New | +$241K | ﹤0.01% | 4535 |
|
Other funds holding MDRX
SPC
TCM
OFCM
MCM
CM
NRCM
PCMI
Citadel Advisors's MDRX Position: Q1 2024 in Review
Citadel Advisors sold out of Veradigm Inc. Common Stock (MDRX) in Q1 2024, closing a stake of 166,114 shares — an estimated $1.74M sold.
Citadel Advisors first reported a position in MDRX in Q2 2013 and held it in 39 quarters. The position peaked at $42.7M in Q1 2022. 35 funds tracked by Wall St. Rank hold MDRX as of Q1 2024.
- Citadel Advisors reported no remaining Veradigm Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Citadel Advisors sold 166,114 Veradigm Inc. Common Stock shares in Q1 2024, an estimated $1.74M.
- Citadel Advisors first reported a position in Veradigm Inc. Common Stock in Q2 2013 and held it in 39 quarters.
- Citadel Advisors's Veradigm Inc. Common Stock position peaked at $42.7M in Q1 2022.
- 35 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q1 2024.
Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.